Advanced searches left 3/3

Nasal Cancer - Europe PMC

Summarized by Plex Scholar
Last Updated: 16 January 2022

* If you want to update the article please login/register

Paranasal Sinus and Nasal Cavity Cancer Treatment (Adult) (PDQ®): Patient Version

This PDQ cancer information summary includes current information about the treatment of adult paranasal sinus and nasal cavity cancer. The PDQ cancer reports are drafted and maintained by editorial boards and keep them up to date. These boards are composed of experts in cancer care and other related to cancer research. The PDQ Adult Treatment Editorial Board reviewed and updated the patient summary. The information in this patient summary was taken from the health professional version, which is updated regularly and updated as needed by the PDQ Adult Treatment Editorial Board.

Source link: https://europepmc.org/article/MED/26389439


Smoking-dependent expression alterations in nasal epithelium reveal immune impairment linked to germline variation and lung cancer risk

In comparison to other cancers, a direct link to lifestyle problems in the form of cigarette smoke has long been established. The majority of all smoking-related lung cancers occur in former smokers, many years after cessation of smoking cessation. Despite extensive study, the molecular causes for persistent lung cancer risk remain unclear. New and former smokers' CT screening has been shown to reduce lung cancer mortality by up to 26%. In both healthy subjects and clinic patients, we developed a questionnaire to measure smoking-related gene expression changes and their reversibility after smoking was outlawed. Integrating previous GWAS data using a transcriptional network technique, we show that the same immune and interferon related pathways are significantly enhanced for genes linked to established genetic risk factors, establishing a causal link between immune changeation and lung cancer risk.

Source link: https://europepmc.org/article/PPR/PPR425029


Effect of Heated Humidified High Flow Nasal Cannula (HFNC) Oxygen Therapy in Dyspnea Patients with Advanced Cancer, a Randomized Controlled Clinical Trial.

Purpose: Heated humidified high flow nasal cannula oxygen therapy is one of the most commonly used oxygen therapy strategies, and it is used to treat dyspnea in elderly cancer patients. Our research aims to investigate the clinical application and investigate the clinical application of HFNC oxygen therapy in dyspnea patients with advanced cancer and determine the safety of the drug. Methods: 60 participants with advanced cancer who needed oxygen therapy from a Grade 3 hospital in China were recruited and randomized to traditional nasal catheter oxygen therapy or HFNC. After HFNC therapy, PaO 2 and RR were both statistically altered 2 hours after HFNC therapy. After HFNC therapy, PaCO 2 and HR were remarkably changed 24 hours after. Conclusion: HFNC oxygen therapy has a positive result, high quality, and is widely accepted by dyspnea patients with advanced cancer.

Source link: https://europepmc.org/article/PPR/PPR421849

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions